These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanism and mode of action of 5-iodo-2-pyrimidinone 2'-deoxyribonucleoside, a potent anti-herpes simplex virus compound, in herpes simplex virus-infected cells. Lewandowski GA; Cheng YC Mol Pharmacol; 1991 Jan; 39(1):27-33. PubMed ID: 1846219 [TBL] [Abstract][Full Text] [Related]
3. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG. Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486 [TBL] [Abstract][Full Text] [Related]
4. 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents. Kumar R Curr Med Chem; 2004 Oct; 11(20):2749-66. PubMed ID: 15544474 [TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2. Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191 [TBL] [Abstract][Full Text] [Related]
6. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2. Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses. Ayisi NK; Gupta SV; Babiuk LA Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988 [TBL] [Abstract][Full Text] [Related]
8. Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy. Cheng YC; Grill S; Ruth J; Bergstrom DE Antimicrob Agents Chemother; 1980 Dec; 18(6):957-61. PubMed ID: 6263181 [TBL] [Abstract][Full Text] [Related]
9. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664 [TBL] [Abstract][Full Text] [Related]
10. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Cheng YC; Huang ES; Lin JC; Mar EC; Pagano JS; Dutschman GE; Grill SP Proc Natl Acad Sci U S A; 1983 May; 80(9):2767-70. PubMed ID: 6302704 [TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs. Schinazi RF; Scott RT; Peters J; Rice V; Nahmias AJ Antimicrob Agents Chemother; 1985 Oct; 28(4):552-60. PubMed ID: 3000291 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. De Clercq E; Descamps J; Verhelst G; Walker RT; Jones AS; Torrence PF; Shugar D J Infect Dis; 1980 May; 141(5):563-74. PubMed ID: 6246180 [TBL] [Abstract][Full Text] [Related]
13. Bacterial Pigment Prodigiosin Demonstrates a Unique Antiherpesvirus Activity That Is Mediated through Inhibition of Prosurvival Signal Transducers. Suryawanshi RK; Koujah L; Patil CD; Ames JM; Agelidis A; Yadavalli T; Patil SV; Shukla D J Virol; 2020 Jun; 94(13):. PubMed ID: 32295926 [TBL] [Abstract][Full Text] [Related]
14. Selective in vitro and in vivo activities of 5-(2-haloalkyl)pyrimidine nucleoside analogs, particularly 5-(2-chloroethyl)-2'-deoxyuridine, against herpes simplex virus. De Clercq E; Rosenwirth B Antimicrob Agents Chemother; 1985 Aug; 28(2):246-51. PubMed ID: 3010841 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections. Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323 [TBL] [Abstract][Full Text] [Related]
16. Incorporation of 5-substituted analogs of deoxycytidine into DNA of herpes simplex virus-infected or - transformed cells without deamination to the thymidine analog. Fox L; Dobersen MJ; Greer S Antimicrob Agents Chemother; 1983 Mar; 23(3):465-76. PubMed ID: 6303214 [TBL] [Abstract][Full Text] [Related]
17. A new promising candidate to overcome drug resistant herpes simplex virus infections. Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164 [TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine. Docherty JJ; Dobson AT; Trimble JJ; Jennings BA Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822 [TBL] [Abstract][Full Text] [Related]
19. Antiviral and virucidal activities against herpes simplex viruses of umesu phenolics extracted from Japanese apricot. Nishide M; Ikeda K; Mimura H; Yoshida M; Mitani T; Hajime Koyama A Microbiol Immunol; 2019 Sep; 63(9):359-366. PubMed ID: 31301156 [TBL] [Abstract][Full Text] [Related]
20. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus]. Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]